This presentation covers the latest insights and updates on how to effectively conduct due diligence for acquisitions in the life sciences sector, considering the dynamic legal, regulatory, and compliance environment.
This program will give an overview of FINRA and will provide viewers with an understanding on how to navigate a FINRA investigation and disciplinary proceeding.